| Date | Stock | Signal | Target | Start Price | Best Price (1Y) | Accuracy | Current Price |
|---|---|---|---|---|---|---|---|
| Sep 10, 2026 |
Abbvie Inc
ABBV
|
BUY |
$315.00
Est. +26%
|
$250.98 | $269.39 |
Pending
|
$265.30
+5.7%
|
| Sep 10, 2026 |
Regeneron Pharmaceuticals, Inc.
REGN
|
BUY |
$920.00
Est. +14%
|
$807.65 | $813.53 |
Pending
|
$801.82
-0.7%
|
| Jul 06, 2026 |
Merck & Co Inc
MRK
|
BUY |
$150.00
Est. +19%
|
$126.05 | $156.91 |
Target Met
|
$148.11
+17.5%
|
| Jul 06, 2026 |
Gilead Sciences, Inc.
GILD
|
BUY |
$155.00
Est. +18%
|
$131.27 | $154.20 |
Bullseye Hit (±1%)
|
$151.37
+15.3%
|
| Dec 10, 2025 |
Pfizer Inc.
PFE
|
BUY |
$29.00
Est. +14%
|
$25.33 | $29.21 |
Bullseye Hit (±1%)
|
$28.17
+11.2%
|
| Dec 10, 2025 |
Merck & Co Inc
MRK
|
BUY |
$120.00
Est. +24%
|
$96.89 | $156.91 |
Target Met
|
$148.11
+52.9%
|
| Oct 02, 2025 |
Roche Holding AG - ADR
RHHBY
|
BUY |
$50.00
Est. +12%
|
$44.83 | $60.85 |
Target Met
|
$55.06
+22.8%
|
| Jun 05, 2024 |
Abbvie Inc
ABBV
|
BUY |
$185.00
Est. +14%
|
$162.14 | $218.66 |
Target Met
|
$265.30
+63.6%
|
| Apr 17, 2024 |
Danaher Corp.
DHR
|
BUY |
$280.00
Est. +17%
|
$240.34 | $281.70 |
Bullseye Hit (±1%)
|
$221.70
-7.8%
|
| Apr 04, 2024 |
Unitedhealth Group Inc
UNH
|
BUY |
$460.00
Est. +1%
|
$454.65 | $630.49 |
Target Met
|
$371.29
-18.3%
|